Patent · US Active

Methods and kits for diagnosing obstructive sleep apnea

US9435814B2 · kind B2 · utility

4Cited by
1References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 6, 2015
Grant dateSep 6, 2016
Priority date
Expiry dateMar 6, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/2864
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The presently-disclosed subject matter provides methods and kits for diagnosing obstructive sleep apnea (OSA) in a subject, such as a human child, wherein a biological sample is provided from the subject and the amount of a Urocortin III peptide is determined from the sample. Further provided are methods for diagnosing OSA in a subject wherein the amount of a Urocortin III peptide and one or more peptides selected from a Uromodulin peptide, an Orosomucoid 1 peptide, and a Kallikrein 1 peptide are determined in a biological sample from a subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.